KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

PEREGRINE CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000764529)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 210,910 Value ($000) $8,700 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 214,364 Value ($000) $8,324 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 288,636 Value ($000) $7,987 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 309,190 Value ($000) $6,867 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 244,043 Value ($000) $4,827 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 239,682 Value ($000) $5,990 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 239,156 Value ($000) $4,465 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	210,910	$8,700	$40.11	$35.20 - $44.42
Q3 2025	214,364	$8,324	$32.49	$26.27 - $39.00
Q2 2025	288,636	$7,987	$25.46	$18.25 - $30.69
Q1 2025	309,190	$6,867	$20.58	$17.82 - $24.31
Q4 2024	244,043	$4,827	$22.82	$19.47 - $28.15
Q3 2024	239,682	$5,990	$24.36	$17.38 - $27.92
Q2 2024	239,156	$4,465	$18.73	$16.56 - $20.52